Paper
21 May 2001 Safety of sequential whole bladder photodynamic therapy (WBPT) in bladder cancer
Unyime O. Nseyo M.D., Donald L. Lamm, Cindy Carpenter
Author Affiliations +
Abstract
Bladder cancer remains a serious public health problem in many parts of the world with an estimated 300,000 new cases a year. In the US, there were 53,200 new cases of bladder cancer with 12,200 deaths in 2000. A majority (75%-90%) of these cancers are diagnosed pathologically as transitional cell carcinoma (TCC). Superficial TCC constitutes 85% of newly diagnosed bladder cancer cases. Superficial bladder cancer includes papillary tumors involving only the mucosa (Ta) or submucosa (T1) and flat carcinoma in suit (CIS). Transurethral resection (TUR) of bladder tumor effectively controls the primary tumors, confirms the superficial or non-muscle invasive nature of the disease, provides cytological and histological tumor characteristics for determining prognostic significance and allows for assessment of the extent of bladder tissue involvement by tumor. Intravesical therapy provides a high concentration of drug in contact with tumor-bearing mucosa for prolonged periods, reduces the likelihood of tumor implantation after resection by destroying viable cancer cells, provides a cytotoxic effect on residual carcinoma, and potentially alters precursor mucosal lesions.
© (2001) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Unyime O. Nseyo M.D., Donald L. Lamm, and Cindy Carpenter "Safety of sequential whole bladder photodynamic therapy (WBPT) in bladder cancer", Proc. SPIE 4244, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XI, (21 May 2001); https://doi.org/10.1117/12.427814
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Bladder

Tumors

Photodynamic therapy

Bladder cancer

Safety

Cancer

Control systems

Back to Top